Anthony T Newall (Anthony Newall)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 5

Top Topics

Coronavirus Disease

Smoking Cessation

Clinical Practice

Top Venues

PharmacoEconomics

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

This page only lists publications with an associated author ORCID identifier.

Publications

Frederick McElwee, Anthony T Newall
The Value of Flexible Vaccine Manufacturing Capacity: Value Drivers, Estimation Methods, and Approaches to Value Recognition in Health Technology Assessment. PharmacoEconomics (2024)
Frederick McElwee, Anthony T Newall
The Value of Flexible Vaccine Manufacturing Capacity: Value Drivers, Estimation Methods, and Approaches to Value Recognition in Health Technology Assessment. PharmacoEconomics 42 (Suppl 2) (2024)
Frederick McElwee, Anthony T Newall
The Value of Flexible Vaccine Manufacturing Capacity: Value Drivers, Estimation Methods, and Approaches to Value Recognition in Health Technology Assessment. PharmacoEconomics 42 (Suppl 2) (2024)
Frederick McElwee, Anthony T Newall
The Value of Flexible Vaccine Manufacturing Capacity: Value Drivers, Estimation Methods, and Approaches to Value Recognition in Health Technology Assessment. PharmacoEconomics 42 (Suppl 2) (2024)
Anthony T Newall, Robert Neil Leong, Josephine F Reyes, Aaron T Curns, Jessica Rudd, Jacqueline Tate, Kristine Macartney, Umesh Parashar
Rotavirus Vaccination Likely to Be Cost Saving to Society in the United States. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 73 (8) (2021)